2021
DOI: 10.1111/jfbc.13604
|View full text |Cite
|
Sign up to set email alerts
|

Potential health benefits of zinc supplementation for the management of COVID‐19 pandemic

Abstract: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent for the Coronavirus Disease 2019 (COVID-19). The COVID-19 pandemic has created unimaginable and unprecedented global health crisis. Since the outbreak of COVID-19, millions of dollars have been spent, hospitalization overstretched with increasing morbidity and mortality. All these have resulted in unprecedented global economic catastrophe. Several drugs and vaccines are currently being evaluated, tested, and administered … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
28
0
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 27 publications
(29 citation statements)
references
References 85 publications
0
28
0
1
Order By: Relevance
“…The modulation of antiviral immunity by zinc can also limit SARS-CoV-2 infection through the upregulation of interferon-alpha (IFN-α) production through the Janus kinase signal transducer and activator of transcription-1 (JAK/STAT1) signaling pathway in leukocytes [62] and increasing its antiviral activity [63]. In addition to its immunomodulatory effects, zinc, as an antiviral agent, exerts its beneficial roles and potential applications in the management of COVID-19, possibly by the enhancement of total antioxidant capacity [64].…”
Section: Discussionmentioning
confidence: 99%
“…The modulation of antiviral immunity by zinc can also limit SARS-CoV-2 infection through the upregulation of interferon-alpha (IFN-α) production through the Janus kinase signal transducer and activator of transcription-1 (JAK/STAT1) signaling pathway in leukocytes [62] and increasing its antiviral activity [63]. In addition to its immunomodulatory effects, zinc, as an antiviral agent, exerts its beneficial roles and potential applications in the management of COVID-19, possibly by the enhancement of total antioxidant capacity [64].…”
Section: Discussionmentioning
confidence: 99%
“…Other antioxidant compounds that have been proposed as potential adjuvants in COVID-19 are zinc [ 260 ], selenium [ 261 ], melatonin [ 262 ], curcumin [ 263 ], N-acetylcystein [ 264 , 265 ], GC4419, a SOD mimetic [ 266 ], colchicine [ 267 ], α-lipoic acid [ 268 ], glutathione [ 269 ], broccoli or glucoraphanin capsules [ 270 ], dypiridamole [ 271 ], cannabidiol [ 272 ], combinations of vitamin D, magnesium, and vitamin B12 [ 273 ], and diammonium glycyrrhizinate with vitamin C [ 274 ].…”
Section: Antioxidants As Neuroprotectors In Patients Infected With Covid-19mentioning
confidence: 99%
“…Supplemental zinc could reverse this with preservation of the ACE2 axis, mitigation of the effects of the ACE axis with decreased inflammation, vasoconstriction, and thromboses [ 25 ].…”
Section: Ace “Adverse” Vs Ace2 “Protective” Axes Of Rasmentioning
confidence: 99%
“…Furthermore, clinical exacerbation that occurs in many high-risk patients at approximately day 8–9 (the beginning of the second week of illness) is thought to represent a “tipping point” with increasing oscillations, dysregulation, and disruption of the “Yin/Yang” balance [ 26 ] usually maintained by the RAS (Table 1 ). This loss of control and predominance of the ACE “adverse” axis [ 27 ] is signaled downstream by Ang II acting via the AT1 receptor to increase vasoconstriction, inflammation, and thromboses, In the lung, Ang II hyperactivity could result in multifocal pneumonia, acute respiratory distress syndrome (ARDS), thromboses, or (systemically) cytokine storm [ 7 , 25 , 27 , 28 ].…”
Section: Hypothesis: Deficiencies Of Zinc and Ace2 Dysregulation And The Tipping Pointmentioning
confidence: 99%